Alexandria Real Estate Equities
ARE
#2319
Rank
โ‚น706.12 B
Marketcap
โ‚น4,086
Share price
-2.38%
Change (1 day)
-51.36%
Change (1 year)
Alexandria Real Estate Equities, Inc. is a real estate investment trust that invests in office buildings and laboratories.

Market capitalization of Alexandria Real Estate Equities (ARE)

Market cap: โ‚น706.12 Billion

As of December 2025 Alexandria Real Estate Equities has a market cap of โ‚น706.12 Billion. This makes Alexandria Real Estate Equities the world's 2319th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Alexandria Real Estate Equities from 1997 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚น706.12 B-52.11%
2024โ‚น1.474 T-19.6%
2023โ‚น1.833 T-7.28%
2022โ‚น1.977 T-24.59%
2021โ‚น2.622 T49.12%
2020โ‚น1.758 T26.36%
2019โ‚น1.391 T55.6%
2018โ‚น894.51 B11.27%
2017โ‚น803.94 B34.05%
2016โ‚น599.72 B37.66%
2015โ‚น435.64 B8.39%
2014โ‚น401.92 B43.68%
2013โ‚น279.73 B16.54%
2012โ‚น240.04 B6.19%
2011โ‚น226.04 B25.27%
2010โ‚น180.44 B37.96%
2009โ‚น130.79 B39.93%
2008โ‚น93.46 B-25.88%
2007โ‚น126.09 B-2.26%
2006โ‚น129.00 B58.69%
2005โ‚น81.29 B28.73%
2004โ‚น63.15 B24.36%
2003โ‚น50.78 B31.02%
2002โ‚น38.76 B19.51%
2001โ‚น32.43 B20.18%
2000โ‚น26.98 B41.96%
1999โ‚น19.01 B14.82%
1998โ‚น16.55 B15.02%
1997โ‚น14.39 B

End of Day market cap according to different sources

On Dec 6th, 2025 the market cap of Alexandria Real Estate Equities was reported to be:

โ‚น706.12 Billion
by Nasdaq info icon info icon
โ‚น706.12 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
โ‚น13.295 T 1,782.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น13.512 T 1,813.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น81.364 T 11,422.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
โ‚น1.780 T 152.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น9.537 T 1,250.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น15.958 T 2,160.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚น5.437 T 670.02%๐Ÿ‡บ๐Ÿ‡ธ USA